Shenzhen Bioeasy Biotechnology Co., Ltd. (300942.SZ)
CNY 8.82
(2.92%)
CNY 8.82
(2.92%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 31.46 Million CNY | -68.73% |
| 2022 | 100.6 Million CNY | 7.19% |
| 2021 | 93.85 Million CNY | 52.39% |
| 2020 | 61.58 Million CNY | 96.53% |
| 2019 | 31.33 Million CNY | 40.6% |
| 2018 | 22.28 Million CNY | 54.85% |
| 2017 | 14.39 Million CNY | 48.76% |
| 2016 | 9.67 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 34.97 Million CNY | 11.16% |
| 2024 Q2 | 41.04 Million CNY | 17.37% |
| 2023 Q4 | 31.46 Million CNY | -50.31% |
| 2023 Q1 | 83.33 Million CNY | -17.17% |
| 2023 Q2 | 68.32 Million CNY | -18.02% |
| 2023 Q3 | 63.31 Million CNY | -7.33% |
| 2023 FY | 31.46 Million CNY | -68.73% |
| 2022 Q1 | 119.29 Million CNY | 27.1% |
| 2022 FY | 100.6 Million CNY | 7.19% |
| 2022 Q4 | 100.6 Million CNY | -48.84% |
| 2022 Q3 | 196.66 Million CNY | -10.43% |
| 2022 Q2 | 219.57 Million CNY | 84.05% |
| 2021 FY | 93.85 Million CNY | 52.39% |
| 2021 Q4 | 93.85 Million CNY | -10.0% |
| 2021 Q3 | 104.29 Million CNY | 8.89% |
| 2021 Q2 | 95.77 Million CNY | 8.78% |
| 2021 Q1 | 88.03 Million CNY | 42.94% |
| 2020 FY | 61.58 Million CNY | 96.53% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q4 | 61.58 Million CNY | 4.72% |
| 2020 Q2 | 64.4 Million CNY | 0.0% |
| 2020 Q3 | 58.81 Million CNY | -8.68% |
| 2019 FY | 31.33 Million CNY | 40.6% |
| 2019 Q4 | 31.33 Million CNY | 0.0% |
| 2019 Q1 | 24.1 Million CNY | 0.0% |
| 2018 FY | 22.28 Million CNY | 54.85% |
| 2017 FY | 14.39 Million CNY | 48.76% |
| 2016 FY | 9.67 Million CNY | 0.0% |